Purpose: The treatment of malignant pleural mesothelioma (MPM) remains controversial. We present a prospective study of patients treated at our institution with neoadjuvant chemotherapy, extrapleural pneumonectomy (EPP), and radical radiotherapy.
Methods: Patients with MPM who were eligible for EPP and multimodality therapy were included in this study.